Clinical Trial

A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants

Name: A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants — clinical trial record (NCT07678463)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The primary purpose of this study is to evaluate the safety and tolerability of QX-4533 following oral administration of single and multiple ascending doses in healthy participants.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-08

Trial Details

NCT Number	NCT07678463
Lead Sponsor	QuantX Biosciences, Inc.
Conditions	Healthy
Enrollment	90 participants
Start Date	2026-07-10
Primary Completion	2026-12-25 (estimated)
Study Completion	2027-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-15